Symptomatic uncomplicated diverticular disease: a critical appraisal

被引:0
|
作者
Ritieni, Camilla [1 ]
Sbarigia, Caterina [1 ]
Scalamonti, Silvia [1 ]
Annibale, Bruno [1 ]
Carabotti, Marilia [1 ]
机构
[1] Sapienza Univ Rome, St Andrea Hosp, Dept Med Surg Sci & Translat Med, Via Grottarossa 1035-1039, Rome, Italy
关键词
Symptomatic uncomplicated diverticular disease; diverticular disease; abdominal pain; abdominal bloating; irritable bowel syndrome; acute diverticulitis; diarrhea; constipation; CLINICAL CHARACTERISTICS DEFINITIONS; PART I METHODS; NATURAL COURSE; RIFAXIMIN; MESALAZINE; DIAGNOSIS; COLON; EPIDEMIOLOGY; PATHOGENESIS; MICROBIOTA;
D O I
10.1080/17474124.2024.2388797
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
IntroductionSymptomatic uncomplicated diverticular disease (SUDD) is a clinical condition included in the spectrum of symptomatic diverticular disease. The symptom profile associated with SUDD is highly heterogeneous, as there are currently discordant definitions, that encompass many clinical scenarios.Areas coveredWe conducted a narrative review to assess the symptom profile and diagnostic criteria of SUDD based on the available evidence. A thorough literature search was performed on PubMed following the SANRA scale. Abdominal pain, regardless of its duration and location, emerges as the cardinal symptom of SUDD, suggesting that it should be central to its diagnosis. Although abdominal bloating and changes in bowel habits are commonly reported, they do not appear to be specifically attributable to SUDD. Other issues considered are the possible overlap with irritable bowel syndrome and the identification of a subcategory of SUDD patients with chronic symptoms following an episode of acute diverticulitis.Expert opinionThe future agenda should include the development of shared diagnostic criteria for SUDD, including well-defined inclusion and exclusion clinical features and symptom patterns.
引用
收藏
页码:315 / 323
页数:9
相关论文
共 50 条
  • [1] Mesalazine in the Treatment of Symptomatic Uncomplicated Diverticular Disease
    Dai, Cong
    Jiang, Min
    Sun, Ming-jun
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2019, 53 (01) : 77 - 78
  • [2] Gut Microbiota in Symptomatic Uncomplicated Diverticular Disease
    Kvasnovsky, Charlotte L.
    Leong, Lex
    Abell, Guy C. J.
    Papagrigoriadis, Savvas
    Bruce, Kenneth D.
    Rogers, Geraint B.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (04) : E71 - E71
  • [3] MANAGEMENT OF SYMPTOMATIC UNCOMPLICATED DIVERTICULAR-DISEASE
    GAEKE, R
    KIRSNER, JB
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 242 (07): : 665 - 665
  • [4] Neurite outgrowth in symptomatic uncomplicated diverticular disease
    De Simone, Veronica
    van Baarle, Lies
    Matteoli, Gianluca
    NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31 (09):
  • [5] Mesalazine and Rifaximin in Symptomatic Uncomplicated Diverticular Disease
    Festi, Davide
    Colecchia, Antonio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (02): : 532 - 532
  • [6] RISKS FACTORS IN SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE
    Gioia, A.
    Schiro, G.
    Corrado, C.
    Rollo, N.
    Severi, C.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 : S120 - S120
  • [7] Prucalopride for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon
    Tursi, Antonio
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2016, 50 (04) : 351 - 351
  • [8] Predictors of Elective Surgery in Symptomatic Uncomplicated Diverticular Disease
    Kvasnovsky, Charlotte L.
    Papagrigoriadis, Savvas
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2015, 221 (04) : S34 - S35
  • [9] Ultrasonographic and Functional Features of Symptomatic Uncomplicated Diverticular Disease
    Maconi, Giovanni
    Dell'Era, Alessandra
    Flor, Nicola
    De Silvestri, Annalisa
    Lavazza, Alessandra
    Ardizzone, Sandro
    Bassotti, Gabrio
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2023, 14 (06)
  • [10] Mesalazine in the Treatment of Symptomatic Uncomplicated Diverticular Disease: Reply
    Tursi, Antonio
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2019, 53 (03) : E130 - E132